000			01277 a2200337 4500
005			20250518035804.0
264		0	_c20210707
008			202107s 0 0 eng d
022			_a1878-1780
024	7		_a10.1016/j.diabet.2019.04.007 _2doi
040			_aNLM _beng _cNLM
100	1		_aPreumont, V
245	0	0	_aCurrent status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials. _h[electronic resource]
260			_bDiabetes & metabolism _c04 2020
300			_a83-88 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aDiabetes Mellitus, Type 1 _xblood
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDrug Administration Schedule
650	0	4	_aGlycated Hemoglobin _xanalysis
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin, Long-Acting _xtherapeutic use
650	0	4	_aObservational Studies as Topic
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aTreatment Outcome
700	1		_aBuysschaert, M
773	0		_tDiabetes & metabolism _gvol. 46 _gno. 2 _gp. 83-88
856	4	0	_uhttps://doi.org/10.1016/j.diabet.2019.04.007 _zAvailable from publisher's website
999			_c29657306 _d29657306